Ellevest, Inc. Albireo Pharma, Inc. Transaction History

Ellevest, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$16.32 - $26.37 $244 - $395	15 Added 250.0%	21 $0
Q2 2021 Jul 13, 2021	SELL	$28.9 - $36.87 $115 - $147	-4 Reduced 40.0%	6 $0
Q4 2020 Feb 04, 2021	BUY	$31.56 - $42.16 $126 - $168	4 Added 66.67%	10 $0
Q2 2020 Jul 06, 2020	BUY	$14.82 - $29.92 $74 - $149	5 Added 500.0%	6 $0
Q1 2020 Apr 13, 2020	BUY	$11.67 - $27.23 $11 - $27	1 New	1 $0

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.